一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> ACS Applied Energy Materials >>article
ACS Applied Energy Materials

ACS Applied Energy Materials

IF: 5.4
Download PDF

Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS.

Published:1 November 2020 DOI: 10.1016/j.intimp.2020.106906 PMID: 33182057
Shradha Bodkhe, Mayuri Nikam, Atul P Sherje, Tabassum Khan, Vasanti Suvarna, Kavit Patel

Abstract

Phosphodiesterase-4 inhibitors (PDE4) are of great interest for the treatment of airway inflammatory diseases due to its broad anti-inflammatory effects. Roflumilast is a selective PDE4 inhibitor that inhibits pulmonary and systemic inflammation and rallies symptoms in airway diseases. Asthma and COPD are common chronic airway inflammatory diseases having incompletely illustrious pathophysiology and clinical manifestations. Recently, the condition called Asthma- COPD Overlap (ACO) has been evolved having the overlapping symptoms of both diseases. The newly discovered PDE4 inhibitor, roflumilast has exposed its potential in the treatment of Asthma, COPD and ACOS. Its mechanism of action in airway inflammatory diseases are said to be exerts by elevating intracellular cAMP and shows its anti-inflammatory action. Roflumilast, a promising therapeutic approach in inflammatory airway diseases, has many significant outcomes. In this review, we have provided various promising clinical evidences of roflumilast in COPD and asthma. However, there is no published clinical evidence to date for the role of roflumilast in ACOS. Nevertheless, there are therapeutic mechanisms that provide a reference for clinical application for ACOS.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Roflumilast 162401-32-3 C17H14Cl2F2N2O3 524 suppliers $5.00-$1789.00
PDE4 antibody 10 suppliers Inquiry

Similar articles

IF:5.4

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap.

ACS Applied Energy Materials Xiaoli Zhang, Yuqing Chen,etc Published: 1 August 2018
IF:2.1

Efficacy and safety profile of roflumilast in a real-world experience.

Journal of thoracic disease Aykut Cilli, Halid Bal,etc Published: 1 April 2019
IF:4.3

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

ACS Applied Electronic Materials Noemi Lois, Evie Gardner,etc Published: 14 July 2020
城步| 广水市| 堆龙德庆县| 穆棱市| 平阴县| 樟树市| 上栗县| 辉县市| 宁阳县| 横峰县| 永济市| 文昌市| 龙口市| 兴业县| 武城县| 白银市| 大厂| 石门县| 阳信县| 普安县| 景东| 岑巩县| 福海县| 十堰市| 且末县| 军事| 绥滨县| 郯城县| 海阳市| 资溪县| 汶上县| 宁海县| 扬中市| 新蔡县| 仁布县| 墨脱县| 云浮市| 团风县| 漳州市| 长春市| 葫芦岛市|